Dicerna Pharmaceuticals Company Profile (NASDAQ:DRNA)

About Dicerna Pharmaceuticals

Dicerna Pharmaceuticals logoDicerna Pharmaceuticals, Inc. is a ribonucleic acid (RNA) interference-based biopharmaceutical company. The Company operates in the segment of discovery, research and development of treatments based on its RNA interference (RNAi) technology platform. The Company is focused on the discovery and development of treatments for rare inherited diseases involving the liver and for cancers that are genetically defined. The Company uses its RNAi technology platform to build a pipeline in these therapeutic areas. The Company develops dacryocystorhinostomy (DCR)-Primary Hyperoxaluria Type 1 (PH1) for the treatment of PH1 by targeting the gene encoding the liver enzyme glycolate oxidase. The Company uses its dicer substrate RNA (DsiRNA)-EX Conjugate technology to develop a subcutaneously injected treatment for PH1. The Company develops DCR-MYC for the treatment of MYC-related cancers, including hepatocellular carcinoma (HCC) and pancreatic neuroendocrine tumors (PNET).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: DRNA
  • CUSIP:
Key Metrics:
  • Previous Close: $5.88
  • 50 Day Moving Average: $3.58
  • 200 Day Moving Average: $3.90
  • 52-Week Range: $2.69 - $15.93
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.13
  • P/E Growth: 0.00
  • Market Cap: $122.03M
  • Outstanding Shares: 20,753,000
  • Beta: 2.28
Profitability:
  • Return on Equity: -75.52%
  • Return on Assets: -68.42%
Debt:
  • Current Ratio: 7.55%
  • Quick Ratio: 7.55%
Additional Links:
Companies Related to Dicerna Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Dicerna Pharmaceuticals (NASDAQ:DRNA) (?)
Ratings Breakdown: 1 Hold Rating, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $13.88 (135.97% upside)

Analysts' Ratings History for Dicerna Pharmaceuticals (NASDAQ:DRNA)
Show:
DateFirmActionRatingPrice TargetDetails
9/28/2016Stifel NicolausReiterated RatingBuy$13.00View Rating Details
8/15/2016Chardan CapitalLower Price TargetNeutral$4.00 -> $3.50View Rating Details
8/5/2016Cowen and CompanyReiterated RatingBuyView Rating Details
6/30/2016Leerink SwannReiterated RatingBuyView Rating Details
5/10/2016Jefferies GroupReiterated RatingBuy$19.00View Rating Details
(Data available from 9/30/2014 forward)

Earnings

Earnings History for Dicerna Pharmaceuticals (NASDAQ:DRNA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2016        
8/4/2016Q216($0.84)($0.75)ViewN/AView Earnings Details
5/9/2016Q116($0.86)($0.76)ViewN/AView Earnings Details
3/10/2016Q415($0.84)($0.76)ViewListenView Earnings Details
11/10/2015Q315($0.84)($0.82)ViewListenView Earnings Details
8/6/2015Q215($0.78)($0.86)ViewN/AView Earnings Details
5/11/2015Q1($0.73)($0.79)$600.00 millionViewListenView Earnings Details
3/12/2015Q414($0.57)($0.57)$1.45 millionViewN/AView Earnings Details
11/6/2014($0.63)($0.63)ViewN/AView Earnings Details
8/7/2014($0.47)($0.64)ViewN/AView Earnings Details
5/13/2014Q114($0.52)($1.02)ViewN/AView Earnings Details
3/27/2014($0.62)($0.20)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Dicerna Pharmaceuticals (NASDAQ:DRNA)
Current Year EPS Consensus Estimate: $-3.17 EPS
Next Year EPS Consensus Estimate: $-2.76 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20162($0.92)($0.85)($0.89)
Q3 20162($0.97)($0.94)($0.96)
Q4 20162($1.07)($1.07)($1.07)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Dicerna Pharmaceuticals (NASDAQ:DRNA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Dicerna Pharmaceuticals (NASDAQ:DRNA)
Insider Ownership Percentage: 27.65%
Institutional Ownership Percentage: 62.38%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/12/2016James B WeissmanInsiderBuy5,000$3.29$16,450.00View SEC Filing  
11/25/2014James E FlynnInsiderSell321,965$11.36$3,657,522.40View SEC Filing  
11/7/2014James E FlynnInsiderSell214,164$9.05$1,938,184.20View SEC Filing  
10/15/2014James E FlynnInsiderSell117,778$10.86$1,279,069.08View SEC Filing  
10/14/2014James E FlynnMajor ShareholderSell36,115$11.02$397,987.30View SEC Filing  
10/10/2014James E FlynnMajor ShareholderSell30,214$12.13$366,495.82View SEC Filing  
2/4/2014James E FlynnInsiderBuy1,000,000$15.00$15,000,000.00View SEC Filing  
2/4/2014Stephen J HoffmanDirectorBuy200,000$15.00$3,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Dicerna Pharmaceuticals (NASDAQ:DRNA)
DateHeadline
fxpips.com logoTraders' Pick: Leading Gainers - QLT Inc. (NASDAQ: QLTI), Dicerna Pharmaceuticals Inc. (NASDAQ: DRNA), Tidewater ... - FxPips.com (NASDAQ:DRNA)
www.fxpips.com - September 30 at 9:45 AM
News IconTime To Put On The Watch List? - Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), 22nd Century Group, Inc ... - The Voice Registrar (NASDAQ:DRNA)
voiceregistrar.com - September 30 at 9:45 AM
News IconLatest Analyst Ratings For Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) - The De Soto Edge (NASDAQ:DRNA)
desotoedge.com - September 29 at 9:42 AM
streetinsider.com logoDicerna Pharma (DRNA): Strategy Shift Should Yield LT Gains - Stifel - StreetInsider.com (NASDAQ:DRNA)
www.streetinsider.com - September 28 at 4:34 PM
News IconDicerna Prioritizes Resources to Advance GalXC Product Candidates (NASDAQ:DRNA)
www.cbs58.com - September 27 at 9:15 AM
4-traders.com logoDicerna Pharmaceuticals : Prioritizes Resources to Advance GalXC™ Product Candidates (NASDAQ:DRNA)
www.4-traders.com - September 26 at 9:23 AM
finance.yahoo.com logo7:31 am Dicerna Pharmaceuticals will focus its resources on its GalXC technology; will discontinue clinical development of DCR-MYC (NASDAQ:DRNA)
finance.yahoo.com - September 26 at 9:23 AM
publicnow.com logoDicerna Prioritizes Resources to Advance GalXC™ Product Candidates (NASDAQ:DRNA)
www.publicnow.com - September 26 at 9:23 AM
News IconDicerna Pharmaceuticals Forecasted to Post FY2017 Earnings of ($4.55) Per Share (DRNA) - Petro Global News 24 (NASDAQ:DRNA)
petroglobalnews24.com - September 23 at 4:29 PM
finance.yahoo.com logoDicerna Pharmaceuticals (DRNA) Worth a Look: Stock Up 6% - Yahoo Finance (NASDAQ:DRNA)
finance.yahoo.com - September 22 at 10:16 AM
capitalcube.com logoDicerna Pharmaceuticals, Inc. :DRNA-US: Earnings Analysis: Q2, 2016 By the Numbers : September 21, 2016 (NASDAQ:DRNA)
www.capitalcube.com - September 21 at 5:12 PM
News IconEarnings Analysis & Update for Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA)? - Frisco Fastball (NASDAQ:DRNA)
friscofastball.com - September 14 at 4:46 PM
News IconEarnings Analysis & Update for Dicerna Pharmaceuticals, Inc ... - Frisco Fastball (NASDAQ:DRNA)
friscofastball.com - September 14 at 4:46 PM
News IconPlacing Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Shares Under the Microscope - National Daily Press (NASDAQ:DRNA)
www.nationaldailypress.com - September 9 at 9:31 AM
publicnow.com logoDicerna to Present at September Investor Conferences (NASDAQ:DRNA)
www.publicnow.com - September 6 at 4:35 PM
News IconHow Analysts & Retail Investors Perceive Dicerna Pharmaceuticals ... - Post News (NASDAQ:DRNA)
www.kentuckypostnews.com - August 21 at 9:13 AM
nasdaq.com logoDicerna Pharmaceuticals (DRNA) Jumps: Stock Rises 7.5% - Nasdaq (NASDAQ:DRNA)
www.nasdaq.com - August 17 at 7:37 AM
finance.yahoo.com logoDicerna Pharmaceuticals (DRNA) Jumps: Stock Rises 7.5% (NASDAQ:DRNA)
finance.yahoo.com - August 16 at 4:46 PM
finance.yahoo.com logoDICERNA PHARMACEUTICALS INC Financials (NASDAQ:DRNA)
finance.yahoo.com - August 13 at 4:38 PM
News IconMy Watchlist for Monday, August 15 (NASDAQ:DRNA)
ac-investor.blogspot.com - August 13 at 8:30 AM
equities.com logoDicerna Pharmaceuticals Inc. (DRNA) Jumps 6.58% on August 05 - Equities.com (NASDAQ:DRNA)
www.equities.com - August 6 at 5:01 PM
finance.yahoo.com logoEdited Transcript of DRNA earnings conference call or presentation 4-Aug-16 8:30pm GMT (NASDAQ:DRNA)
finance.yahoo.com - August 5 at 4:43 PM
sg.finance.yahoo.com logoDicerna Pharmaceuticals posts 2Q loss (NASDAQ:DRNA)
sg.finance.yahoo.com - August 4 at 10:24 PM
twst.com logoDicerna Pharmaceuticals Inc.: Dicerna Reports Second Quarter 2016 Financial and Operational Results (NASDAQ:DRNA)
www.twst.com - August 4 at 4:53 PM
publicnow.com logoDicerna Reports Second Quarter 2016 Financial and Operational Results (NASDAQ:DRNA)
www.publicnow.com - August 4 at 4:53 PM
biz.yahoo.com logoQ2 2016 Dicerna Pharmaceuticals Inc Earnings Release - After Market Close (NASDAQ:DRNA)
biz.yahoo.com - August 4 at 8:30 AM
publicnow.com logoDicerna to Report Second Quarter 2016 Financial Results and Host Conference Call on August 4, 2016 (NASDAQ:DRNA)
www.publicnow.com - July 28 at 4:28 PM
equities.com logoDicerna Pharmaceuticals Inc. (DRNA) Jumps 6.09% on July 27 - Equities.com (NASDAQ:DRNA)
www.equities.com - July 27 at 10:22 PM
News IconIncreased Stock Volatility Watch: Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) - Engelwood Daily (NASDAQ:DRNA)
www.engelwooddaily.com - July 21 at 8:09 AM
News IconInsiders Increasing Positions in: Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) - Press Telegraph (NASDAQ:DRNA)
presstelegraph.com - July 21 at 8:09 AM
equities.com logoDicerna Pharmaceuticals Inc. (DRNA) Drops 7.54% on July 19 - Equities.com (NASDAQ:DRNA)
www.equities.com - July 21 at 8:09 AM
fiscalstandard.com logoBroker Outlook For Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) - Fiscal Standard (NASDAQ:DRNA)
www.fiscalstandard.com - July 20 at 8:44 AM
News IconHeightened Volatility Spotted on Shares of: Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) - Engelwood Daily (NASDAQ:DRNA)
www.engelwooddaily.com - July 19 at 9:58 PM
equities.com logoDicerna Pharmaceuticals Inc. (DRNA) Jumps 5.29% on July 18 - Equities.com (NASDAQ:DRNA)
www.equities.com - July 19 at 10:48 AM
News IconShares Experiencing a Downtrend: Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) - TGP (NASDAQ:DRNA)
telanaganapress.com - July 16 at 8:06 AM
News IconIncreased Volatility Noted on Shares of: Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) - Engelwood Daily (NASDAQ:DRNA)
www.engelwooddaily.com - July 16 at 8:06 AM
equities.com logoDicerna Pharmaceuticals Inc. (DRNA) Jumps 7.26% on July 15 - Equities.com (NASDAQ:DRNA)
www.equities.com - July 16 at 8:06 AM
News IconCrowd Rating and Earnings Recap for Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) - Telanagana Press (NASDAQ:DRNA)
telanaganapress.com - July 15 at 7:55 AM
equities.com logoDicerna Pharmaceuticals Inc. (DRNA) Drops 7.04% on July 13 - Equities.com (NASDAQ:DRNA)
www.equities.com - July 14 at 10:09 PM
News IconDicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:DRNA)
telanaganapress.com - July 14 at 4:55 PM
News IconDicerna Pharmaceuticals Incorporated (NASDAQ:DRNA) Shorted Shares Increased By 5.33% - Press Telegraph (NASDAQ:DRNA)
presstelegraph.com - July 14 at 6:18 AM
News IconShare Volatility Watch for: Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) - Engelwood Daily (NASDAQ:DRNA)
www.engelwooddaily.com - July 13 at 4:50 PM
News IconDicerna Pharmaceuticals Inc's Stock Is Sell After Today's Huge Decline - Consumer Eagle (NASDAQ:DRNA)
www.consumereagle.com - July 13 at 4:50 PM
news.cmlviz.com logoDicerna Pharmaceuticals Inc Stock Momentum Hits Weakness - CML News (NASDAQ:DRNA)
news.cmlviz.com - July 13 at 8:58 AM
kcregister.com logoWhy Making Dramatic Moves: Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), BP p.l.c. (NYSE:BP), Pfizer Inc. (NYSE ... - KC Register (NASDAQ:DRNA)
www.kcregister.com - July 13 at 8:58 AM
News IconAre Analysts Bullish Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) After Last Week? - Consumer Eagle (NASDAQ:DRNA)
www.consumereagle.com - July 13 at 8:58 AM
News IconDicerna Pharmaceuticals Inc (NASDAQ:DRNA) Institutional Investor Positioning - Consumer Eagle (NASDAQ:DRNA)
www.consumereagle.com - July 13 at 8:58 AM
News IconStock Volatility Focus for: Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) - Engelwood Daily (NASDAQ:DRNA)
www.engelwooddaily.com - July 11 at 4:42 PM
News IconDicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:DRNA)
www.engelwooddaily.com - July 11 at 4:42 PM
biz.yahoo.com logoDICERNA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:DRNA)
biz.yahoo.com - July 11 at 4:02 PM

Social

Dicerna Pharmaceuticals (NASDAQ:DRNA) Chart for Friday, September, 30, 2016


Last Updated on 9/30/2016 by MarketBeat.com Staff